| Cationic amphiphilic peptides with cancer-selective toxicity F Schweizer European journal of pharmacology 625 (1-3), 190-194, 2009 | 568 | 2009 |
| Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination GG Zhanel, CD Lawson, H Adam, F Schweizer, S Zelenitsky, ... Drugs 73, 159-177, 2013 | 488 | 2013 |
| Imipenem–relebactam and meropenem–vaborbactam: two novel carbapenem-β-lactamase inhibitor combinations GG Zhanel, CK Lawrence, H Adam, F Schweizer, S Zelenitsky, M Zhanel, ... Drugs 78, 65-98, 2018 | 373 | 2018 |
| Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli GG Zhanel, P Chung, H Adam, S Zelenitsky, A Denisuik, F Schweizer, ... Drugs 74, 31-51, 2014 | 362 | 2014 |
| New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin GG Zhanel, D Calic, F Schweizer, S Zelenitsky, H Adam, ... Drugs 70, 859-886, 2010 | 360 | 2010 |
| Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold B Findlay, GG Zhanel, F Schweizer Antimicrobial agents and chemotherapy 54 (10), 4049-4058, 2010 | 352 | 2010 |
| Cefiderocol: a siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative bacilli GG Zhanel, AR Golden, S Zelenitsky, K Wiebe, CK Lawrence, HJ Adam, ... Drugs 79, 271-289, 2019 | 333 | 2019 |
| Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development MV Jain, AM Paczulla, T Klonisch, FN Dimgba, SB Rao, K Roberg, ... Journal of cellular and molecular medicine 17 (1), 12-29, 2013 | 316 | 2013 |
| Glycosamino acids: building blocks for combinatorial synthesis—implications for drug discovery F Schweizer Angewandte chemie international edition 41 (2), 230-253, 2002 | 292 | 2002 |
| Antibiotic hybrids: the next generation of agents and adjuvants against Gram-negative pathogens? R Domalaon, T Idowu, GG Zhanel, F Schweizer Clinical microbiology reviews 31 (2), 10.1128/cmr. 00077-17, 2018 | 278 | 2018 |
| Review of eravacycline, a novel fluorocycline antibacterial agent GG Zhanel, D Cheung, H Adam, S Zelenitsky, A Golden, F Schweizer, ... Drugs 76, 567-588, 2016 | 243 | 2016 |
| Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008) GG Zhanel, M DeCorby, H Adam, MR Mulvey, M McCracken, ... Antimicrobial agents and Chemotherapy 54 (11), 4684-4693, 2010 | 233 | 2010 |
| Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin GG Zhanel, CD Lawson, S Zelenitsky, B Findlay, F Schweizer, H Adam, ... Expert review of anti-infective therapy 10 (4), 459-473, 2012 | 217 | 2012 |
| Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens GG Zhanel, R Love, H Adam, A Golden, S Zelenitsky, F Schweizer, ... Drugs 75, 253-270, 2015 | 206 | 2015 |
| Ceftaroline: A Novel Broad-Spectrum Cephalosporin with Activity against Meticillin-Resistant Staphylococcus aureus GG Zhanel, G Sniezek, F Schweizer, S Zelenitsky, PRS Lagacé-Wiens, ... Drugs 69, 809-831, 2009 | 185 | 2009 |
| Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007–11 study GG Zhanel, HJ Adam, MR Baxter, J Fuller, KA Nichol, AJ Denisuik, ... Journal of Antimicrobial Chemotherapy 68 (suppl_1), i7-i22, 2013 | 175 | 2013 |
| Oritavancin: mechanism of action GG Zhanel, F Schweizer, JA Karlowsky Clinical infectious diseases 54 (suppl_3), S214-S219, 2012 | 170 | 2012 |
| Combinatorial synthesis of carbohydrates. F Schweizer, O Hindsgaul Current Opinion in Chemical Biology 3 (3), 291-298, 1999 | 116 | 1999 |
| Design, synthesis, and antibacterial activities of neomycin− lipid conjugates: polycationic lipids with potent gram-positive activity S Bera, GG Zhanel, F Schweizer Journal of medicinal chemistry 51 (19), 6160-6164, 2008 | 109 | 2008 |
| Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin GG Zhanel, A Lam, F Schweizer, K Thomson, A Walkty, E Rubinstein, ... American journal of clinical dermatology 9, 245-254, 2008 | 107 | 2008 |
